Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Share-based Compensation (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Share-based Compensation for 3 consecutive years, with $10.1 million as the latest value for Q1 2026.

  • Quarterly Share-based Compensation rose 2102.18% to $10.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $45.7 million through Jan 2026, up 1845.16% year-over-year, with the annual reading at $24.3 million for FY2025, 1531.12% up from the prior year.
  • Share-based Compensation for Q1 2026 was $10.1 million at Kestra Medical Technologies, up from $8.7 million in the prior quarter.
  • The five-year high for Share-based Compensation was $22.3 million in Q2 2025, with the low at $329000.0 in Q1 2024.
  • Average Share-based Compensation over 3 years is $5.4 million, with a median of $1.1 million recorded in 2024.
  • Peak annual rise in Share-based Compensation hit 5635.99% in 2025, while the deepest fall reached 39.51% in 2025.
  • Over 3 years, Share-based Compensation stood at $1.1 million in 2024, then skyrocketed by 671.21% to $8.7 million in 2025, then increased by 16.81% to $10.1 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $10.1 million, $8.7 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.